BHAV Acquisition II, a blank check company targeting robotics, EVs, fintech, advanced computing and energy tech, lowered the ...

OPay, a digital bank and fintech platform in Nigeria and other emerging markets, announced terms for its IPO on Friday.The ...

Lycia Therapeutics, a Phase 1 biotech developing protein degraders for food allergy and Graves' disease, raised $318 million ...

Windward Bio Group, a Switzerland-based Phase 2/3 biotech developing antibodies for respiratory and dermatologic diseases, filed on Friday with the SEC to raise up to $100 million in an initial public ...

One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year’s last potential mega IPO.Africa-focused digital bank and fintech platform OPay (OPAY) plans ...

One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings.Allergy and autoimmune biotech Lycia Therapeutics (LYCA) priced its upsized IPO at ...

Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO ...

Lycia Therapeutics, a Phase 1 biotech developing protein degraders for food allergy and Graves' disease, announced terms for its IPO on Tuesday.The South San Francisco, CA-based company plans to raise ...

Africa-linked IPOs are having a strong year. Seven companies with significant African operations have raised at least $100 ...

Klook Technology, a pan-Asian online travel booking platform, withdrew its plans for an initial public offering on Friday.

Rezera, a Phase 3-ready biotech developing oral NLRP3 inhibitors for inflammatory diseases, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering.Rezera is ...

Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, raised $150 million ...